Research & Literature
Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.
Top Authors
Top Institutions
Finding nearby institutions...
University of Freiburg
Freiburg im Breisgau, Germany
The University of Melbourne
Melbourne, Australia
Humboldt-Universität zu Berlin
Berlin, Germany
National Institutes of Health
Bethesda, United States
University of Auckland
Auckland, New Zealand
Medizinische Hochschule Hannover
Hanover, Germany
Austrian Academy of Sciences
Vienna, Austria
University Hospital of Wales
Cardiff, United Kingdom
Royal Free London NHS Foundation Trust
London, United Kingdom
University of Helsinki
Helsinki, Finland
References
References (53)
- 1
Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency.
Fliegauf M, Bryant VL, Frede N, et al.
American journal of human genetics 2015; (97(3)):389-403.
PMID: 26279205 - 2
CVID Associated with Systemic Amyloidosis.
Esenboga S, Çagdas Ayvaz D, Saglam Ayhan A, et al.
Case reports in immunology 2015; (2015()):879179 doi:10.1155/2015/879179.
PMID: 26346511 - 3
Clinical and laboratory correlates of lung disease and cancer in adults with idiopathic hypogammaglobulinaemia.
Brent J, Guzman D, Bangs C, et al.
Clinical and experimental immunology 2016; (184(1)):73-82 doi:10.1111/cei.12748.
PMID: 26646609 - 4
Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency.
Hanitsch LG, Löbel M, Mieves JF, et al.
Vaccine 2016; (34(21)):2417-2423 doi:10.1016/j.vaccine.2016.03.091.
PMID: 27055021 - 5
NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation.
Boztug H, Hirschmugl T, Holter W, et al.
Journal of clinical immunology 2016; (36(6)):533-40 doi:10.1007/s10875-016-0306-1.
PMID: 27338827 - 6
Vaccination in Primary Immunodeficiency Disorders.
Sobh A, Bonilla FA
The journal of allergy and clinical immunology. In practice 2016; (4(6)):1066-1075 doi:10.1016/j.jaip.2016.09.012.
PMID: 27836056 - 7
When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach.
Jolles S, Chapel H, Litzman J
Clinical and experimental immunology 2017; (188(3)):333-341 doi:10.1111/cei.12915.
PMID: 28000208 - 8
Clinical Profile, Dosing, and Quality-of-Life Outcomes in Primary Immune Deficiency Patients Treated at Home with Immunoglobulin G: Data from the IDEaL Patient Registry.
Kearns S, Kristofek L, Bolgar W, et al.
Journal of managed care & specialty pharmacy 2017; (23(4)):400-406 doi:10.18553/jmcp.2017.23.4.400.
PMID: 28345437 - 9
Specific Antibody Deficiency: Controversies in Diagnosis and Management.
Perez E, Bonilla FA, Orange JS, Ballow M
Frontiers in immunology 2017; (8()):586 doi:10.3389/fimmu.2017.00586.
PMID: 28588580 - 10
Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial.
Parta M, Kelly C, Kwatemaa N, et al.
Journal of clinical immunology 2017; (37(6)):548-558 doi:10.1007/s10875-017-0422-6.
PMID: 28752258 - 11
Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID).
Mieves JF, Wittke K, Freitag H, et al.
Current allergy and asthma reports 2017; (17(11)):78 doi:10.1007/s11882-017-0749-3.
PMID: 28983790 - 12
Human NF-κB1 Haploinsufficiency and Epstein-Barr Virus-Induced Disease-Molecular Mechanisms and Consequences.
Hoeger B, Serwas NK, Boztug K
Frontiers in immunology 2017; (8()):1978 doi:10.3389/fimmu.2017.01978.
PMID: 29403474 - 13
Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans.
Tuijnenburg P, Lango Allen H, Burns SO, et al.
The Journal of allergy and clinical immunology 2018; (142(4)):1285-1296 doi:10.1016/j.jaci.2018.01.039.
PMID: 29477724 - 14
Loss of NF-κB1 Causes Gastric Cancer with Aberrant Inflammation and Expression of Immune Checkpoint Regulators in a STAT-1-Dependent Manner.
O'Reilly LA, Putoczki TL, Mielke LA, et al.
Immunity 2018; (48(3)):570-583.e8 doi:10.1016/j.immuni.2018.03.003.
PMID: 29562203 - 15
Immunosuppressive therapy with rituximab in common variable immunodeficiency.
Pecoraro A, Crescenzi L, Galdiero MR, et al.
Clinical and molecular allergy : CMA 2019; (17()):9 doi:10.1186/s12948-019-0113-3.
PMID: 31080365 - 16
Late-Onset Antibody Deficiency Due to Monoallelic Alterations in NFKB1.
Schröder C, Sogkas G, Fliegauf M, et al.
Frontiers in immunology 2019; (10()):2618 doi:10.3389/fimmu.2019.02618.
PMID: 31803180 - 17
Efficacy of immunoglobulin replacement therapy and azithromycin in severe asthma with antibody deficiency.
Tiotiu A, Salvator H, Jaussaud R, et al.
Allergology international : official journal of the Japanese Society of Allergology 2020; (69(2)):215-222 doi:10.1016/j.alit.2019.10.011.
PMID: 31812484 - 18
Identification of Novel Genetic Variants in CVID Patients With Autoimmunity, Autoinflammation, or Malignancy.
Christiansen M, Offersen R, Jensen JMB, et al.
Frontiers in immunology 2019; (10()):3022 doi:10.3389/fimmu.2019.03022.
PMID: 32047491 - 19
Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations.
Lorenzini T, Fliegauf M, Klammer N, et al.
The Journal of allergy and clinical immunology 2020; (146(4)):901-911 doi:10.1016/j.jaci.2019.11.051.
PMID: 32278790 - 20
A Pathogenic Missense Variant in NFKB1 Causes Common Variable Immunodeficiency Due to Detrimental Protein Damage.
Fliegauf M, Krüger R, Steiner S, et al.
Frontiers in immunology 2021; (12()):621503 doi:10.3389/fimmu.2021.621503.
PMID: 33995346 - 21
Vaccination in PADs.
Milito C, Soccodato V, Collalti G, et al.
Vaccines 2021; (9(6)) doi:10.3390/vaccines9060626.
PMID: 34207916 - 22
Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency.
Li J, Lei WT, Zhang P, et al.
The Journal of experimental medicine 2021; (218(11)) doi:10.1084/jem.20210566.
PMID: 34473196 - 23
Defining the Role of Nuclear Factor (NF)-κB p105 Subunit in Human Macrophage by Transcriptomic Analysis of NFKB1 Knockout THP1 Cells.
Somma D, Kok FO, Kerrigan D, et al.
Frontiers in immunology 2021; (12()):669906 doi:10.3389/fimmu.2021.669906.
PMID: 34721373 - 24
Resolving the polygenic aetiology of a late onset combined immune deficiency caused by NFKB1 haploinsufficiency and modified by PIK3R1 and TNFRSF13B variants.
Hargreaves CE, Dhalla F, Patel AM, et al.
Clinical immunology (Orlando, Fla.) 2022; (234()):108910 doi:10.1016/j.clim.2021.108910.
PMID: 34922003 - 25
Vulnerability to Meningococcal Disease in Immunodeficiency Due to a Novel Pathogenic Missense Variant in NFKB1.
Anim M, Sogkas G, Schmidt G, et al.
Frontiers in immunology 2021; (12()):767188 doi:10.3389/fimmu.2021.767188.
PMID: 35003082 - 26
Common Variable Immunodeficiency-Associated Cancers: The Role of Clinical Phenotypes, Immunological and Genetic Factors.
Bruns L, Panagiota V, von Hardenberg S, et al.
Frontiers in immunology 2022; (13()):742530 doi:10.3389/fimmu.2022.742530.
PMID: 35250968 - 27
Haploidentical Stem Cell Transplantation After TCR-αβ+ and CD19+ Cells Depletion In Children With Congenital Non-Malignant Disease.
Giardino S, Bagnasco F, Falco M, et al.
Transplantation and cellular therapy 2022; (28(7)):394.e1-394.e9 doi:10.1016/j.jtct.2022.04.002.
PMID: 35405368 - 28
[Prophylactic and therapeutic management of increased susceptibility to infection in patients with immunodeficiency].
Hanitsch LG
Der Internist 2022; (63(5)):484-492 doi:10.1007/s00108-022-01326-8.
PMID: 35412057 - 29
Common Variable Immunodeficiency and Neurodevelopmental Delay Due to a 13Mb Deletion on Chromosome 4 Including the NFKB1 Gene: A Case Report.
Franco-Jarava C, Valenzuela I, Riviere JG, et al.
Frontiers in immunology 2022; (13()):897975 doi:10.3389/fimmu.2022.897975.
PMID: 35784294 - 30
Detrimental NFKB1 missense variants affecting the Rel-homology domain of p105/p50.
Fliegauf M, Kinnunen M, Posadas-Cantera S, et al.
Frontiers in immunology 2022; (13()):965326 doi:10.3389/fimmu.2022.965326.
PMID: 36105815 - 31
Long-term follow up of families with pathogenic NFKB1 variants reveals incomplete penetrance and frequent inflammatory sequelae.
Tuovinen EA, Kuismin O, Soikkonen L, et al.
Clinical immunology (Orlando, Fla.) 2023; (246()):109181 doi:10.1016/j.clim.2022.109181.
PMID: 36356849 - 32
Antibody and T-cell responses to coronavirus disease 2019 vaccination in common variable immunodeficiency and specific antibody deficiency.
Rosenthal JA, Papa MP, Sanz M, et al.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2023; (130(6)):743-751.e3 doi:10.1016/j.anai.2023.01.025.
PMID: 36736722 - 33
Evaluation of Psychiatric Symptomatology, Quality of Life, and Caregiver Burden in Mothers and Children with Primary Immunodeficiency.
Kılıç N, Kaya Ş, Taşçı G, et al.
Allergologia et immunopathologia 2023; (51(6)):45-53 doi:10.15586/aei.v51i6.927.
PMID: 37937495 - 34
Common Variable Immunodeficiency.
Remiker A, Bolling K, Verbsky J
The Medical clinics of North America 2024; (108(1)):107-121 doi:10.1016/j.mcna.2023.06.012.
PMID: 37951645 - 35
A large deletion in a non-coding regulatory region leads to NFKB1 haploinsufficiency in two adult siblings.
Fusaro M, Coustal C, Barnabei L, et al.
Clinical immunology (Orlando, Fla.) 2024; (261()):110165 doi:10.1016/j.clim.2024.110165.
PMID: 38423196 - 36
Anxiety in Polish adult patients with inborn errors of immunity: a cross-sectional study.
Grochowalska K, Ziętkiewicz M, Nowicka-Sauer K, et al.
Frontiers in psychiatry 2024; (15()):1293935 doi:10.3389/fpsyt.2024.1293935.
PMID: 38516260 - 37
Truncating NFKB1 variants cause combined NLRP3 inflammasome activation and type I interferon signaling and predispose to necrotizing fasciitis.
Nurmi K, Silventoinen K, Keskitalo S, et al.
Cell reports. Medicine 2024; (5(4)):101503 doi:10.1016/j.xcrm.2024.101503.
PMID: 38593810 - 38
A qualitative study to explore the burden of disease in activated phosphoinositide 3-kinase delta syndrome (APDS).
Hitchcock I, Skrobanski H, Matter E, et al.
Orphanet journal of rare diseases 2024; (19(1)):203 doi:10.1186/s13023-024-03215-9.
PMID: 38760658 - 39
Limitations in the clinical utility of vaccine challenge responses in the evaluation of primary antibody deficiency including Common Variable Immunodeficiency Disorders.
Ameratunga R, Longhurst H, Leung E, et al.
Clinical immunology (Orlando, Fla.) 2024; (266()):110320 doi:10.1016/j.clim.2024.110320.
PMID: 39025346 - 40
Health-related quality of life in patients with inborn errors of immunity: A systematic review and meta-analysis.
Xiao N, Huang X, Yang D, et al.
Preventive medicine 2024; (186()):108079 doi:10.1016/j.ypmed.2024.108079.
PMID: 39053518 - 41
Common Variable Immunodeficiency Clinical Manifestations Are Shaped by Presence and Type of Heterozygous NFKB1 Variants.
Yin J, Hayes KM, Ong MS, et al.
The journal of allergy and clinical immunology. In practice 2025; (13(3)):639-646 doi:10.1016/j.jaip.2024.12.002.
PMID: 39672378 - 42
Genetic Counseling in Pediatric Inborn Errors of Immunity: Perspective Piece on Current Practice and Considerations.
DeBortoli E, McInerney-Leo A, Macintosh R, et al.
The journal of allergy and clinical immunology. In practice 2025; (13(8)):1918-1927 doi:10.1016/j.jaip.2025.03.052.
PMID: 40252833 - 43
Common variable immunodeficiency due to a novel variant in NFKB1 with a neonatal presentation of parechovirus meningitis and sepsis-like illness.
Szczawińska-Popłonyk A, Popłonyk N, Bernat-Sitarz K, et al.
Allergologia et immunopathologia 2025; (53(3)):31-40 doi:10.15586/aei.v53i3.1307.
PMID: 40342112 - 44
"It's a Godsend": Parental experiences of genomic testing for paediatric inborn errors of immunity.
Clark A, DeBortoli E, Blancoe M, et al.
European journal of human genetics : EJHG 2025; (33(10)):1342-1349 doi:10.1038/s41431-025-01917-7.
PMID: 40730688 - 45
The Presentation, Diagnosis, and Management of Autosomal Dominant Common Variable Immunodeficiency Type XII with NFKB1 Mutation and Autoimmune Neutropenia Treated with Allogenic Stem Cell Transplantation.
Gold M, Kannan C, Schofield A, et al.
Hematology reports 2025; (17(5)) doi:10.3390/hematolrep17050049.
PMID: 41148944 - 46
Common Variable Immunodeficiency Disorders: A perspective from New Zealand.
Ameratunga R, J Longhurst H, Lehnert K, et al.
Clinical reviews in allergy & immunology 2025; (68(1)):105 doi:10.1007/s12016-025-09099-2.
PMID: 41324804 - 47
Clinical, genetic, and functional characterization of novel NFKB1 variants in Chinese patients with primary immunodeficiency.
Zhang J, Cai H, Zhu T, Shen M
Clinical and experimental immunology 2026; (220(1)) doi:10.1093/cei/uxag033.
PMID: 42252100 - 48
Patient and caregiver perspectives on transition from pediatric to adult care in inborn errors of immunity: a Polish multicenter survey.
Będzichowska A, Tomaszewska A, Napiórkowska-Baran K, et al.
Frontiers in immunology 2026; (17()):1816943 doi:10.3389/fimmu.2026.1816943.
PMID: 42433362 - 49
Shared Decision-Making and Health-Related Quality of Life in the Diagnosis and Management of Patients With Inborn Errors of Immunity.
Lawrence MG, Kim VHD, Orange JS, Scherzer R
The journal of allergy and clinical immunology. In practice 2026; doi:10.1016/j.jaip.2026.07.010.
PMID: 42447994 - 50
Clinical and immunological characterization of NFKB1 haploinsufficiency in Japan.
Moriya K, Kamiyama Y, Ogino R, et al.
Frontiers in immunology 2026; (17()):1866459 doi:10.3389/fimmu.2026.1866459.
PMID: 42488646 - 51
Multidisciplinary Delphi consensus on malignancy screening in patients with common variable immunodeficiency.
Cabanero-Navalon MD, de Andrés-Martín A, Gil AA, et al.
Frontiers in immunology 2026; (17()):1897051 doi:10.3389/fimmu.2026.1897051.
PMID: 42676356 - 52
Standardized Human Phenotype Ontology annotation enables high-quality phenotypic data capture in a real-world common variable immunodeficiency cohort.
Campos LC, Favreau É, Greene D, et al.
The Journal of allergy and clinical immunology 2026; doi:10.1016/j.jaci.2026.08.027.
PMID: 42767568 - 53
Genotype-phenotype analysis in 333 individuals with heterozygous variants in NFKB1.
Armbruster SM, Caballero-Oteyza A, Bartsch O, et al.
Journal of human immunity 2027; (3(1)) doi:10.70962/jhi.20260076.
PMID: 42895832